Press Releases Medicare Quietly Gifted AbbVie’s Blockbuster Drug Seven Extra Years Before Price Negotiations August 6, 2026
Reports Medicare Quietly Gifted AbbVie’s Blockbuster Drug Seven Extra Years Before Price Negotiations August 6, 2026
Letters, Testimony & Filings State Medical Boards Should Oppose AI-Enabled Prescription Renewal Systems July 30, 2026
Letters, Testimony & Filings Testimony Before the Food and Drug Administration’s Pharmacy Compounding Advisory Committee (PCAC) Regarding Emideltide Free Base and Emideltide Acetate July 24, 2026
Letters, Testimony & Filings Testimony Before the Food and Drug Administration’s Pharmacy Compounding Advisory Committee Regarding Placing MOTS-c on the 503A Bulks List: No Human Studies or Proven Benefits, But Possible Risks July 23, 2026
Letters, Testimony & Filings Testimony Before the Food and Drug Administration’s Pharmacy Compounding Advisory Committee About BPC-157 (Free Base) and BPC-157 (Acetate) July 23, 2026